Parkman Healthcare Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.4M Buy
2024
Q1
Sell
2023
Q4
$3.46M Sell
2023
Q3
$3.81M Sell
2023
Q2
$5.72M Buy
2023
Q1
$4.78M Buy
2022
Q4
$3.39M Buy
2022
Q3
$3.04M Buy
2022
Q2
$2.56M Sell
2022
Q1
$3.52M Buy
2021
Q4
$3.05M Buy
2021
Q3
$2.68M Hold
2021
Q2
$3.09M Buy